In this edition of Carterra’s Scientist to Scientist Interview, luminary scientist and leader Andrew Bradbury PhD, Chief Scientific Officer of Specifica, discusses how they discovered SARS-CoV-2 neutralizing antibodies in just weeks. Daniel Bedinger PhD, Applications Science Team Lead from Carterra and Andrew also discuss next generation antibody library platforms and how HT-SPR technology powers their work.

Posted by Dan Bedinger, PhD